首页 | 本学科首页   官方微博 | 高级检索  
     

利声显在超声导向植入式微波留置固化治疗肝癌时 的血管定位和疗效判断价值
引用本文:沈延政,黄敏,严禹,邓学东,孙勤,周轶群. 利声显在超声导向植入式微波留置固化治疗肝癌时 的血管定位和疗效判断价值[J]. 中国医学影像技术, 2001, 17(2): 178-179
作者姓名:沈延政  黄敏  严禹  邓学东  孙勤  周轶群
作者单位:南京医科大学附属苏州医院 苏州超声医学研究室,
基金项目:江苏省科委科技发展计划立项项目 !(BS99349)
摘    要:目的,探讨在超声导向植入式微波留置固治疗肝癌时,应用利声显作血管树定位和治疗后判断疗效的价值。方法 28例肝癌,作44例次微波凝固治疗,治疗前应用利声显超声造影,显示肿瘤内血管树,以血管树主干作为凝固治疗的重点,治疗后再次利声超声造影,观察肿瘤内血流变化,判断疗效,结果 44例次均清晰显示肿瘤内血管树主,并以此作为凝固治疗的重点,经复查随访肿瘤区内未发现血流,结论 以利声显超声造影显示的血管树主干作为凝固治疗的重点,经复查随访肿瘤区内均未发现血流,结论 以利声显超声造影显示的血管树主干作为凝固治疗的重点,可提高疗效,建议将利声显造影多普勒检查作为判断微波凝固治疗疗效的金标准。

关 键 词:利声显 微波 治疗 肝癌
文章编号:1003-3289(2001)02-0178-02
收稿时间:2000-08-09
修稿时间:2000-08-09

Value of Levovist on Vessel Location and Curative Effect Evaluation of US-guided Planted Microwave Liver Cancer Coagulation Therapy
SHEN Yan-zheng,HUANG Min,YAN Yu,DENG Xue-dong,SUN Qin and ZHOU Yi-qun. Value of Levovist on Vessel Location and Curative Effect Evaluation of US-guided Planted Microwave Liver Cancer Coagulation Therapy[J]. Chinese Journal of Medical Imaging Technology, 2001, 17(2): 178-179
Authors:SHEN Yan-zheng  HUANG Min  YAN Yu  DENG Xue-dong  SUN Qin  ZHOU Yi-qun
Affiliation:Suzhou Research Laboratory of Ultrasonic Medicine, Affiliated Suzhou Hospital, Nanjiang Medical University, Suzhou 215001, China;Suzhou Research Laboratory of Ultrasonic Medicine, Affiliated Suzhou Hospital, Nanjiang Medical University, Suzhou 215001, China;Suzhou Research Laboratory of Ultrasonic Medicine, Affiliated Suzhou Hospital, Nanjiang Medical University, Suzhou 215001, China;Suzhou Research Laboratory of Ultrasonic Medicine, Affiliated Suzhou Hospital, Nanjiang Medical University, Suzhou 215001, China;Suzhou Research Laboratory of Ultrasonic Medicine, Affiliated Suzhou Hospital, Nanjiang Medical University, Suzhou 215001, China;Suzhou Research Laboratory of Ultrasonic Medicine, Affiliated Suzhou Hospital, Nanjiang Medical University, Suzhou 215001, China
Abstract:Objective To investigate the value of Levovist on vessel location and curative effect evaluation of us guided planted microwave coagulation therapy for liver cancer. Methods 28 patients with liver cancer received microwave coagulation therapy for 44 times. Compared the blood flow inside tumor before and after Levovist ultrasound contrast . Results The main branches of vessel tree were showed clearly in 44 patients. The main branch was considered as a key area of coagulation therapy. No blood flow were seen inside tumor after treatment. Conclusion Levovist contrast is a better way for microwave coagulation therapy. It could be a gold standard of curative effect evaluation in coagulation therapy. [
Keywords:Levovist  Microwave  Therapy  Liver cancer
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《中国医学影像技术》浏览原始摘要信息
点击此处可从《中国医学影像技术》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号